An efficient protocol, with optimized sample preparation steps, i.e., protein extractions from tissue, pellet digestion and SPE, was successfully implemented for the first time to quantitate C9ORF72 isoforms level in a cohort of human brain samples from C9ORF72 or non-genetic FTD patients and control individuals. This evidence concerns the gene C9orf72 and frontotemporal dementia.